High level of Fc epsilon receptor I-bindable immunoglobulin E in the tear fluid and increased immunoglobulin E-saturated cells in the giant papillae of vernal keratoconjunctivitis patients

Japanese Journal of Ophthalmology

Volumn 46, Issue 4, 2002, Pages 357-363

  Ebihara, Nobuyuki ^a   Okumura, Ko ^a   Nakayasu, Kiyoo ^a   Kanai, Atsushi ^a   Ra, Chisei ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fc epsilon receptor I; Immunoglobulin E; Vernal keratoconjunctivitis

Indexed keywords

FC EPSILON RECEPTOR I; FC RECEPTOR; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; LACRIMAL FLUID; LACRIMAL FLUID LEVEL; MEASUREMENT; PRIORITY JOURNAL; RISK FACTOR; VERNAL CONJUNCTIVITIS;

ANTIBODIES, MONOCLONAL; CELL COUNT; CONJUNCTIVITIS, ALLERGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN E; RECEPTORS, IGE; TEARS;

EID: 0036661640     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(02)00507-5     Document Type: Article

References (40)

1. Gounni A.S., Lamkhioued B., Delaporte E., Capron A., Kinet J.P., Capron M. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature. 367:1994;183-186.
2. Bieber T., de la Salle H., Wollenberg A.et al. Human Langerhans cells express the high affinity receptor for IgE (FcεRI). J Exp Med. 175:1992;1285-1290.
3. Wang B., Rieger A., Kilgus O.et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J Exp Med. 175:1992;1353-1365.
4. Maurer D., Fiebiger E., Reininger B.et al. Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J Exp Med. 179:1994;745-750.
5. 2 production by monocytes in atopic dermatitis. Int Arch Allergy Immunol. 108:1995;247-253.
6. Maurer D., Fiebiger E., Ebner C.et al. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRI-α and FcεRI-γ chains and can use this receptor for IgE-mediated allergen presentation. J Immunol. 157:1996;607-616.
7. Mudde G., Bruijnzeel-Kiimen C., Van Reijsen F., Boland G., Bruijzeel-Kromen P. IgE dependent allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis. Immunology. 8:1989;773.
8. Buckley R.J. Vernal keratoconjunctivitis. Int Ophthalmol Clin. 28:1988;303-308.
9. Fukagawa K., Saito H., Azuma N., Tsubota K., Iikura Y., Oguchi Y. Histamine and tryptase levels in allergic conjunctivitis and vernal keratoconjunctivitis. Cornea. 13:1994;345-348.
10. Butrus S.I., Ochsner K.I., Abelson M.B., Schwartz L.B. The level of tryptase in human tears. Ophthalmology. 97:1990;1678-1683.
11. Montan P.G., Biberfeld P.J., Scheynius A. IgE, IgE receptor, and other immunocytochemical markers in atopic and nonatopic patients with vernal keratoconjunctivitis. Ophthalmology. 102:1995;725-732.
12. Allansmith M.R., Baird R.S., Greiner J.V. Vernal conjunctivitis and contact lens-associated giant papillary conjunctivitis compared and contrasted. Am J Ophthalmol. 87:1979;544-555.
13. Henriquez A.S., Kenyon K.R., Allansmith M.R. Mast cell ultrastructure. Arch Ophthalmol. 99:1981;1266-1272.
14. Weeke B., Poulson L.H. Diagnostic tests for allergy. Holgate S.T., Church M.K. Allergy. 1993;Gower Medical Publishing, London. 11.1-11.4.
15. Ishizaka T, Ishizaka K. IgE molecules and their receptor sites on human basophil granulocytes. Immunology series, Vol 1. Mechanisms in Allergy: Reagin-mediated Hypersensitivity. New York: Marcel Dekker, 1973:221-234.
16. Godfry R.C., Gradidge C.F., Hawksley M.R., Elliott E.V. Differences in binding affinity of human IgE for receptors in chopped human lung. Immunology. 35:1978;581-587.
17. Conroy M.C., Adkinson N.F., Lichtenstein L.M. Jr. Passive sensitization of human basophils. evidence for heterogeneity in the IgE molecule Int Arch Allergy Appl Immunol. 60:1979;106-109.
18. Lehrer S.B., McCants M.L., Farris P.N., Bazin H. Passive cutaneous anaphylaxis inhibition evidence for heterogeneity in IgE mast cell interaction. Immunology. 44:1981;711-716.
19. Wada N., Okumura K., Ra C. Evaluation of FcεRI-bindable human IgE with an enzyme-linked immunosorbent assay using a recombinant soluble form of the human FcεRI ectodomain. Allergol Int. 46:1997;173-180.
20. Jurgens M., Wollenberg A., Hanau D., de la Salle H., Bieber T. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE. Fc epsilon RI. J Immunol. 155:1995;5184-5189.
21. Bieber T., Jürgens M., Wollenberg A., Stander E., Hanau D., de la Salle H. Characterization of the protein tyrosine phosphatase CD45 on human epidermal Langerhans cells. Eur J Immunol. 25:1995;317-321.
22. Foster C.S., Rice B.A., Dutt J.E. Immunopathology of atopic keratoconjunctivitis. Ophthalmology. 98:1991;1190-1196.
23. Wollenberg A., Kraft S., Hanau D., Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesion skin of atopic eczema. J Invest Dermatol. 106:1996;446-453.
24. Bieber T., Ring J. In vivo modulation of the high affinity receptor for IgE, FcεRI, on human epidermal Langerhans cells. Int Arch Allegy Clin Immunol. 99:1992;204.
25. Wollenberg A., Wen S.P., Bieber T. Langerhans cells phenotyping. a new tool for the differential diagnosis of eczematous skin disease Lancet. 346:1995;1626.
26. Yoshida A., Imayama S., Sugai S., Kawano Y., Ishibashi T. Increased number of IgE positive Langerhans cells in the conjunctiva of patients with atopic dermatitis. Br J Ophthalmol. 81:1997;402-406.
27. Yamaguchi M., Lantz C.S., Dettgen H.C.et al. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo. evidence for a novel amplification mechanism in IgE-dependent reactions J Exp Med. 185:1997;663-672.
28. Blank U., Ra C., Miller L., White K., Metzger H., Kinet J.P. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature. 337:1989;187-189.
29. Ra C., Jouvin M.H.E., Kinet J.P. Complete structure of the mouse mast cell receptor for IgE (FcεRI) and surface expression of chimeric receptor (rat-mouse-human) on transfected cells. J Biol Chem. 264:1989;15323-15327.
30. Dombrouicz D., Flamand V., Brigman K.K., Koller B.H., Kinet J.P. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell. 75:1993;969-976.
31. Matsumoto S., Wada N., Ohno S., Okumura K., Ra C. Evaluation of FcεRI-binding serum IgE in patients with ocular allergic diseases. Allergol Int. 48:1999;183-187.
32. Nawata Y., Koike T., Hosokawa H., Tomioka H., Yoshida S. Anti-IgE autoantibody in patients with atopic dermatitis. J Immunol. 135:1985;478-482.
33. Koike T., Tsutsumi A., Nawata Y., Tomioka H., Yoshida S. Prevalence and role of IgG anti-IgE autoantibody in allergic disorders. Monogr Allergy. 26:1989;165-167.
34. Stadler B.M., Gang Q., Vogel M. IgG anti-IgE autoantibodies in immunoregulation. Int Arch Allergy Appl Immunol. 94:1991;83-86.
35. Hayashi S., Suto H., Wada N., Ogawa H., Okumura K., Ra C. Detection of anti-IgE and anti-FcεRI-α chain autoantibodies in patients with atopic dermatitis. Allergol Int. 49:2000;47-54.
36. Hide M., Francis D.M., Grattan C.E.H., Hakimi J., Kichan J.P., Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 328:1993;1599-1604.
37. Fiebiger E., Maurer D., Holub H.et al. Serum IgE autoantibodies directed against the α chain of FcεRI. A selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest. 96:1995;2606-2612.
38. Fiebiger E., Stingl G., Maurer D. Anti-IgE and anti-FcεRI autoantibodies in clinical allergy. Curr Opin Immunol. 8:1996;764-789.
39. Ra C., Kuromitsu S., Hirose T., Yasuda S., Furuichi K., Okumura K. Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction. Int Immunol. 5:1993;47-54.
40. Naito K., Hirama M., Okumura K., Ra C. Recombinant soluble form of the human high affinity receptor for IgE inhibits anaphylactic shock in mice. J Allergy Clin Immunol. 97:1996;773-780.